Prescriber Compliance With Liver Monitoring Guidelines for Pazopanib in the Postapproval Setting: Results From a Distributed Research Network.
Journal Information
Full Title: J Patient Saf
Abbreviation: J Patient Saf
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Health Services
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Disclosure of Potential Conflicts of Interest: S.S. and J.J.N. were employees and owned stock in GlaxoSmithKline at the time that the study was designed and executed. M.P.P.v.H.-S. is an employee of the PHARMO Institute. This independent research institute performs financially supported studies for government and related health-care authorities and several pharmaceutical companies. B.L.N. is an employee of Evidera, which received funding from GSK for this study. S.A.H. was an employee of New England Research Institutes, which received funding from GSK for this study."
"Disclosure of Potential Conflicts of Interest: S.S. and J.J.N. were employees and owned stock in GlaxoSmithKline at the time that the study was designed and executed. M.P.P.v.H.-S. is an employee of the PHARMO Institute. This independent research institute performs financially supported studies for government and related health-care authorities and several pharmaceutical companies. B.L.N. is an employee of Evidera, which received funding from GSK for this study. S.A.H. was an employee of New England Research Institutes, which received funding from GSK for this study. This study was funded by GlaxoSmithKline."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025